Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kobinger GP"'
Autor:
Alexander Bello, Massimo Giunti, Alberto Auricchio, Giulia Cesi, Gary P. Kobinger, Elena Marrocco, Agostina Puppo, Maria Laura Bacci, Michele Della Corte, Enrico Maria Surace, Settimio Rossi, Francesca Simonelli, Anna Manfredi
Publikováno v:
PLoS ONE
PLoS ONE; Vol 8
PLoS ONE, Vol 8, Iss 3, p e59025 (2013)
PLoS ONE; Vol 8
PLoS ONE, Vol 8, Iss 3, p e59025 (2013)
Recombinant adeno-associated viral (AAV) vectors are known to safely and efficiently transduce the retina. Among the various AAV serotypes available, AAV2/5 and 2/8 are the most effective for gene transfer to photoreceptors (PR), which are the most r
Autor:
Lanini S; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Montaldo C; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Nicastri E; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Vairo F; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Agrati C; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Petrosillo N; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Scognamiglio P; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Antinori A; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Puro V; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Di Caro A; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., De Carli G; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Navarra A; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Agresta A; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Cimaglia C; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Palmieri F; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., D'Offizi G; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Marchioni L; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Kobinger GP; Centre de Recherche en Infectiologie de l'Université Laval, Quebec City, QC, Canada., Maeurer M; Champalimaud Centre for the Unknown, Lisbon, Portugal.; University of Mainz, Mainz, Germany., Girardi E; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Capobianchi MR; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy., Zumla A; Department of Infection, Division of Infection and Immunity, University College London, London, United Kingdom.; NHS Foundation Trust, London, United Kingdom., Locatelli F; Department of Pediatric Hematology and Oncology IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy., Ippolito G; National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.
Publikováno v:
PloS one [PLoS One] 2020 Dec 28; Vol. 15 (12), pp. e0244129. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2020).
Autor:
Kozak RA; Department of Laboratory Medicine & Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Fraser RS; Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada., Biondi MJ; Arthur Labatt Family School of Nursing, Western University, London, Ontario, Canada.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Majer A; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Medina SJ; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Griffin BD; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Kobasa D; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada., Stapleton PJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Urfano C; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Babuadze G; Infectious Diseases Research Centre, Université Laval, Quebec City, Quebec, Canada., Antonation K; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Fernando L; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Booth S; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Lillie BN; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada., Kobinger GP; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Infectious Diseases Research Centre, Université Laval, Quebec City, Quebec, Canada.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Apr 06; Vol. 14 (4), pp. e0008105. Date of Electronic Publication: 2020 Apr 06 (Print Publication: 2020).
Publikováno v:
PloS one [PLoS One] 2019 Dec 23; Vol. 14 (12), pp. e0227018. Date of Electronic Publication: 2019 Dec 23 (Print Publication: 2019).
Autor:
Welch SR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Ritter JM; Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., McElroy AK; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Division of Pediatric Infectious Disease, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Center for Vaccine Research Pittsburgh, Pennsylvania, United States of America., Harmon JR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Coleman-McCray JD; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Scholte FEM; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Kobinger GP; Department of Microbiology, Immunology and Infectious Diseases, Université Laval, Quebec City, Quebec, Canada., Bergeron É; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Zaki SR; Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Nichol ST; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Spengler JR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2019 Dec 02; Vol. 15 (12), pp. e1008183. Date of Electronic Publication: 2019 Dec 02 (Print Publication: 2019).
Autor:
McCarthy SD; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Majchrzak-Kita B; Division of Advanced Diagnostics, Infection and Immunity Group, Toronto General Research Institute, Toronto, Ontario, Canada., Racine T; Special Pathogens Program, National Microbiology Laboratory, Winnipeg, Manitoba, Canada., Kozlowski HN; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Baker DP; Biogen, Cambridge, Massachusetts, United States of America., Hoenen T; Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Winnipeg, Manitoba, Canada., Fish EN; Division of Advanced Diagnostics, Infection and Immunity Group, Toronto General Research Institute, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Branch DR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Division of Advanced Diagnostics, Infection and Immunity Group, Toronto General Research Institute, Toronto, Ontario, Canada.; Centre for Innovation, Canadian Blood Services, Toronto, Ontario, Canada.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2016 Jan 11; Vol. 10 (1), pp. e0004364. Date of Electronic Publication: 2016 Jan 11 (Print Publication: 2016).
Autor:
de La Vega MA; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada., Stein D; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2015 Nov 12; Vol. 11 (11), pp. e1005221. Date of Electronic Publication: 2015 Nov 12 (Print Publication: 2015).
Autor:
Puppo A; Telethon Institute of Genetics and Medicine, Napoli, Italy., Bello A, Manfredi A, Cesi G, Marrocco E, Della Corte M, Rossi S, Giunti M, Bacci ML, Simonelli F, Surace EM, Kobinger GP, Auricchio A
Publikováno v:
PloS one [PLoS One] 2013; Vol. 8 (3), pp. e59025. Date of Electronic Publication: 2013 Mar 08.
Autor:
Yoshida-Amano Y; Biological Science Laboratories, Kao Corporation, Haga, Tochigi, Japan., Hachiya A, Ohuchi A, Kobinger GP, Kitahara T, Takema Y, Fukuda M
Publikováno v:
PloS one [PLoS One] 2012; Vol. 7 (7), pp. e41160. Date of Electronic Publication: 2012 Jul 23.
Autor:
Patel A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada., Dong JC, Trost B, Richardson JS, Tohme S, Babiuk S, Kusalik A, Kung SK, Kobinger GP
Publikováno v:
PloS one [PLoS One] 2012; Vol. 7 (8), pp. e43802. Date of Electronic Publication: 2012 Aug 24.